Zacks Research Forecasts Stronger Earnings for ProAssurance

Key Points

• Zacks Research has revised its earnings per share estimate for ProAssurance's Q3 2025 to $0.29, up from $0.28, maintaining a "Strong-Buy" rating for the stock.
• ProAssurance's latest quarterly earnings report showed earnings of $0.52 per share, significantly exceeding the consensus estimate of $0.19, although revenue declined by 19.9% year-over-year.
• Hedge funds and institutional investors own 85.58% of ProAssurance's stock, with major investments increasing significantly during the second quarter of this year.

ProAssurance Corporation (NYSE:PRA - Free Report) - Equities research analysts at Zacks Research boosted their Q3 2025 earnings per share estimates for shares of ProAssurance in a report issued on Tuesday, September 23rd. Zacks Research analyst Team now expects that the insurance provider will post earnings of $0.29 per share for the quarter, up from their prior estimate of $0.28. Zacks Research currently has a "Strong-Buy" rating on the stock. The consensus estimate for ProAssurance's current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance's Q3 2026 earnings at $0.30 EPS and Q4 2026 earnings at $0.28 EPS.

ProAssurance Stock Performance

PRA stock opened at $23.86 on Thursday. ProAssurance has a twelve month low of $13.00 and a twelve month high of $24.14. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of 25.38 and a beta of 0.12. The company has a quick ratio of 0.26, a current ratio of 0.26 and a debt-to-equity ratio of 0.33. The firm's fifty day simple moving average is $23.83 and its two-hundred day simple moving average is $22.97.

ProAssurance (NYSE:PRA - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The insurance provider reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.33. The company had revenue of $271.94 million for the quarter, compared to analyst estimates of $266.72 million. ProAssurance had a return on equity of 5.62% and a net margin of 4.33%.ProAssurance's quarterly revenue was down 19.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.23 EPS.

Hedge Funds Weigh In On ProAssurance

A number of large investors have recently bought and sold shares of PRA. Russell Investments Group Ltd. boosted its stake in shares of ProAssurance by 356.2% during the second quarter. Russell Investments Group Ltd. now owns 1,405 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 1,097 shares during the period. Quantbot Technologies LP purchased a new position in shares of ProAssurance during the first quarter worth approximately $47,000. GAMMA Investing LLC boosted its holdings in shares of ProAssurance by 307.3% in the first quarter. GAMMA Investing LLC now owns 2,073 shares of the insurance provider's stock valued at $48,000 after purchasing an additional 1,564 shares during the period. CWM LLC grew its stake in ProAssurance by 95.9% in the first quarter. CWM LLC now owns 2,204 shares of the insurance provider's stock worth $51,000 after purchasing an additional 1,079 shares in the last quarter. Finally, Longfellow Investment Management Co. LLC bought a new position in shares of ProAssurance during the 1st quarter worth $75,000. Hedge funds and other institutional investors own 85.58% of the company's stock.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.